Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe

Updated on: April 18,2024

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe

Updated on:April 18,2024

Researchers uncover potential biomarkers of positive response to immunotherapy

by Denise Heady,University of California, Los AngelesResponse to ICI or MAPKi therapy is associated with increased T cell infiltration and enhanced interferon gamma (IFNγ) pathway activity in th

Updated on: January 30,2024

Researchers uncover potential biomarkers of positive response to immunotherapy

by Denise Heady,University of California, Los AngelesResponse to ICI or MAPKi therapy is associated with increased T cell infiltration and enhanced interferon gamma (IFNγ) pathway activity in th

Updated on:January 30,2024

Unemployment due to brain or spine cancer is linked to more pain and depression

byAmerican Academy of NeurologyCredit: Pixabay/CC0 Public DomainPeople who are unemployed due to brain or spine cancer may experience more severe symptoms of pain, discomfort, anxiety and depres

Updated on: January 02,2024

Unemployment due to brain or spine cancer is linked to more pain and depression

byAmerican Academy of NeurologyCredit: Pixabay/CC0 Public DomainPeople who are unemployed due to brain or spine cancer may experience more severe symptoms of pain, discomfort, anxiety and depres

Updated on:January 02,2024

Researchers identify potential new combination treatment for pancreatic cancer

by Denise Heady,University of California, Los AngelesPancreatic cancer (the cancer cells are seen here) is the third leading cause of cancer-related deaths in the United States. Credit: Universi

Updated on: March 01,2024

Researchers identify potential new combination treatment for pancreatic cancer

by Denise Heady,University of California, Los AngelesPancreatic cancer (the cancer cells are seen here) is the third leading cause of cancer-related deaths in the United States. Credit: Universi

Updated on:March 01,2024

Researchers find effective drug combinations for glioblastoma in mice

by The Spanish National Cancer Research CentreTelomeres (red) in mouse embryonic fibroblasts; DNA damage (green) caused by ERK inhibition. ERK is an enzyme in the RAS pathway whose inhibition lea

Updated on: June 04,2024

Researchers find effective drug combinations for glioblastoma in mice

by The Spanish National Cancer Research CentreTelomeres (red) in mouse embryonic fibroblasts; DNA damage (green) caused by ERK inhibition. ERK is an enzyme in the RAS pathway whose inhibition lea

Updated on:June 04,2024

New tumor-selective light treatment could kill breast cancer cells with greater accuracy and improve tumor control

byNational University of SingaporeGraphical abstract. Credit:ACS Nano(2023). DOI: 10.1021/acsnano.3c01916Breast cancer is the most common cancer affecting women in Singapore. Treatme

Updated on: January 13,2024

New tumor-selective light treatment could kill breast cancer cells with greater accuracy and improve tumor control

byNational University of SingaporeGraphical abstract. Credit:ACS Nano(2023). DOI: 10.1021/acsnano.3c01916Breast cancer is the most common cancer affecting women in Singapore. Treatme

Updated on:January 13,2024

Treatment strategy for locally advanced liver cancer via novel tri-modality therapy

byThe University of Hong KongCredit: Pixabay/CC0 Public DomainA pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of C

Updated on: January 15,2024

Treatment strategy for locally advanced liver cancer via novel tri-modality therapy

byThe University of Hong KongCredit: Pixabay/CC0 Public DomainA pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of C

Updated on:January 15,2024

Study unravels a cause of resistance to novel drug in patients with acute leukemia

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA new targeted drug has not only sparked remissions in patients with a common form of leukemia but also induced the cancer cells t

Updated on: February 23,2024

Study unravels a cause of resistance to novel drug in patients with acute leukemia

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA new targeted drug has not only sparked remissions in patients with a common form of leukemia but also induced the cancer cells t

Updated on:February 23,2024

Researchers uncover novel gene that regulates leukemia development and progression

by Pusan National UniversityResearchers from Pusan National University find that suppressing the expression of SURF4 reduces pathologic processes that contribute to leukemia progression. Credit: Profe

Updated on: February 23,2024

Researchers uncover novel gene that regulates leukemia development and progression

by Pusan National UniversityResearchers from Pusan National University find that suppressing the expression of SURF4 reduces pathologic processes that contribute to leukemia progression. Credit: Profe

Updated on:February 23,2024

Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of

Updated on: April 10,2024

Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of

Updated on:April 10,2024

Metastasizing cancer cells modify bone remodeling with small RNA secretion

by Tokyo Medical and Dental UniversityIn the bone metastatic microenvironment, the crosstalk between metastasized cancer cells and the surrounding bone cells is critical for the formation of the osteo

Updated on: April 01,2024

Metastasizing cancer cells modify bone remodeling with small RNA secretion

by Tokyo Medical and Dental UniversityIn the bone metastatic microenvironment, the crosstalk between metastasized cancer cells and the surrounding bone cells is critical for the formation of the osteo

Updated on:April 01,2024

New research shows unmet support needs can lead to worse clinical outcomes

by Sylvester Comprehensive Cancer CenterCredit: CC0 Public DomainCancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency depart

Updated on: January 12,2024

New research shows unmet support needs can lead to worse clinical outcomes

by Sylvester Comprehensive Cancer CenterCredit: CC0 Public DomainCancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency depart

Updated on:January 12,2024